Stage IV lung cancer survivor Lindi Campbell shares what it was like being diagnosed with advanced disease, how a new treatment has helped her live longer, and why she chose to dedicate her work toward ending the stigma around lung cancer.
What to Know About Treatment Options Before and After Surgery for Early-Stage Non-Small Cell Lung Cancer
In this podcast, Dr. Charu Aggarwal and Dr. Ryan Gentzler discuss what people with early-stage non-small cell lung cancer should know about treatment options before and after lung surgery, including what to consider when weighing treatment options and questions to ask the health care team.
In this podcast, 3 members of the Cancer.Net Editorial Board discuss new research presented at the 2023 ASCO Annual Meeting in non-small cell lung cancer, small cell lung cancer, and mesothelioma.
2023 ASCO Annual Meeting Research Round Up: Progress in Preventing Melanoma Recurrence and Improving Equity in Cancer Care
In this podcast, 2 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting about preventing melanoma recurrence and reducing cancer disparities.
What People in Asian American and Pacific Islander Communities Should Know About Their Cancer Risk: An Expert Perspective
Dr. Tingting Zhang shares what people in Asian American and Pacific Islander communities should know about cancer risk, including the types of cancer they may be more at risk for, the importance of screening for these cancers, and resources available to help.
ASCO Annual Meeting 2023: Improving Outcomes in Glioma, Hodgkin Lymphoma, Lung Cancer, Ovarian Cancer, and Rectal Cancer
The ASCO Annual Meeting is being held June 2 to 6. Several notable studies will be presented today. Topics include radiation therapy in rectal cancer, osimertinib for lung cancer, vorasidenib for grade 2 glioma, nivolumab for Hodgkin lymphoma, and mirvetuximab soravtansine for ovarian cancer.
Tumors With KRAS G12C Mutation Respond to Adagrasib and Using Toripalimab to Treat Stage III Lung Cancer: The ASCO Plenary Series
Read about 2 studies from the April 2023 ASCO Plenary Series, which highlights the use of adagrasib to target several solid tumors with a KRAS G12C mutation and the use of toripalimab to treat stage III non-small cell lung cancer before and after surgery.
Immunotherapy Combination That Targets TIGIT Receptor Shows Promise in Non-Small Cell Lung Cancer: The ASCO Plenary Series
Read research from the December 2022 session of the ASCO Plenary Series, which explores combining immunotherapy for advanced non-small cell lung cancer with high PD-L1.
Physical therapist Sarah Saulsberry, PT, COMT, shares how prehabilitation can help people with lung cancer prepare for surgery, how it can help during recovery, and 4 exercises to get started with prehabilitation at home.
In this podcast, Dr. Xiuning Le discusses research from the 2022 North America Conference on Lung Cancer, including 3 studies evaluating targeted therapy treatments for people with non-small cell lung cancer.